8-KOther EventsExhibits & Filings

CVS HEALTH Corp 8-K Report, Corporate Update (Feb 26, 2007)

Filed February 26, 2007For Securities:CVS

Summary

This Form 8-K filing from CVS Corporation (CVS) on February 26, 2007, primarily serves to update investors on the ongoing merger process with Caremark Rx, Inc. The key development reported is the Delaware Court of Chancery's denial of a motion to enjoin the merger. However, the court stipulated that a Caremark stockholder vote could proceed only after supplemental disclosures regarding shareholder appraisal rights and financial advisor fees were made. Consequently, Caremark mailed a proxy statement supplement on February 24, 2007, and rescheduled its special shareholder meeting to March 16, 2007. CVS also adjourned its own shareholder meeting to a later date in March to align with these developments, indicating continued progress towards the merger despite a temporary procedural delay.

Key Highlights

  • 1Delaware Court of Chancery denied plaintiff's motion to block the CVS-Caremark merger.
  • 2Court requires supplemental disclosures from Caremark regarding appraisal rights and financial advisor fees before stockholder vote.
  • 3Caremark Rx, Inc. mailed a proxy statement supplement on February 24, 2007.
  • 4Caremark rescheduled its special shareholder meeting to approve the merger to March 16, 2007.
  • 5CVS Corporation adjourned its special shareholder meeting (originally March 9, 2007) to a later date in March.
  • 6The merger proxy statement/prospectus filed on January 19, 2007, is being updated with this information.
  • 7This filing indicates ongoing legal and procedural steps necessary for the completion of the CVS-Caremark merger.

Frequently Asked Questions

This filing updates investors on the progress and procedural developments of the proposed merger between CVS Corporation and Caremark Rx, Inc. It specifically addresses a court ruling that impacted the timeline for shareholder votes.

No, the merger was not blocked. The Delaware Court of Chancery denied a motion to enjoin the merger. However, the court mandated that Caremark must provide additional disclosures to its shareholders before they can vote on the transaction.

Caremark Rx, Inc. rescheduled its special meeting of shareholders to approve the merger to March 16, 2007, after making the required supplemental disclosures regarding appraisal rights and financial advisor fees.

CVS Corporation has adjourned its own special meeting of shareholders to approve the merger. They intend to adjourn it again to a later date in March to coordinate with the revised timeline following the court's ruling and Caremark's actions.